發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  _____     ______               ___     __   _   
 |__  //   /_   _//   ____      / _ \\  | || | || 
   / //     -| ||-   |    \\   / //\ \\ | '--' || 
  / //__    _| ||_   | [] ||  |  ___  ||| .--. || 
 /_____||  /_____//  |  __//  |_||  |_|||_|| |_|| 
 `-----`   `-----`   |_|`-`   `-`   `-` `-`  `-`  
                     `-`